GOOD CONNECTIONS FOR STAYING ON-TOP OF THIS WAR ON CHINA'S DEADLY GIFT SENT AROUND THE WORLD AS COVID-19: www.covid19-druginteractions.org/prescribing-resources liverpool-covid19.s3.eu-west-2.amazonaws.com/lnilz6wi5y5qxy4qw9l5zek8tzvc

Good Review for Capricor CAP-1002 Study as further will be released within this next reporting qtr. link.springer.com/.../s00395-020-0795-1.pdf This drug has great efficacy for COVID-19 U.S. hot-spots or uptick of cases for a number of patients meeting ICU status of care. This SARS-CoV2 COVID-19 Infectious Diseases Society of America--Adobe.pdf for current standing protocol treatments has a phenomenal pulse of what doctors are facing on the frontlines as of the current date. www.idsociety.org/.../covid-19-guideline-treatment-and-management/ Trying to educate as many as I can so, the more you know, the more you can spread the word for those who are dealing with COVID-19 themselves, or have a family member or close friends diagnosed and admitted into the hospital. with SARS-CoV2 pre-ICU or already admitted into the ICU.

The thoughts and statements/questions you posed in your comments are quite true. The critical part of finding the sources for hope I pointed out clearly with naming Dr. Stephen J. Gould John Hopkins, and Dr. Eduardo Marbán as a renowned Bio as linked here: https://bio.cedars-sinai.org/marbane/index.html

This link is the history of active or status of Phase Trials involving Capricor patents and licensed intellectual Pipeline: clinicaltrials.gov/.../results=

The article posted in April of 2020 had quite remarkable results of critical ICU Intubated patients on a ventilator. www.bioworld.com/.../434747-capricors-covid-19-success-gets-fda-and-market-attention

ALSO: www.cedars-sinai.org/search.html

William, you're spot on, when it relates to the myriad of efforts towards fighting the many human organs of lungs, heart, liver, kidney, brain, and Nero/Chemical DNA, RNA, T-Cell responses in the fight against SARCoV2 and the many unprecedented efforts in either repurposing already FDA approved treatment/drugs/therapies or finding the most brilliant minds of our times--we are all within the petri-dish--of this China Born Novel Coronavirus Panadimic killing already well over 650,000 to date.

Here is another, I hope is a helpful link to exercise one's research in getting a real handle on where smart money and untold advances are being made daily due to a world at war with COVID-19. www.prnewswire.com/.../...therapies-301074466.html

I want to also say; a quick hello and hear your prayer and concerns Andrew Armstrong.

The success of Oxford with AsTraZenca's AZN potent T-Cell antibody response reported and Inovio along with MRNA Moderna. But, even more important, is the Biotech Companies such as Capricor CAPR as one of many you have to watch as I gave price targets going out 3-12 months with possible M&A candidate bringing well over $24 - $32 dollar PT. Look for upcoming breaking news with Capricor and others within what they report in their next SEC filings.

I am appreciating the many conference calls being informative by Capricor, with their efforts with FDA fast-track BLA approvals on the near-term horizon for CAP-1002 several indicated uses, as my article discovers for many then to do their own due diligence.

Hopefully, due diligence in assembling an investment strategy; and more so, to start to build real hope and seeing prayers being answered all around us, as God is truly present and helping the coming of Block-buster Disrupters, as we are all on the right path when it relates towards the use of vaccines developed with Exosomes as I have highlighted within the article.

Last link for research purposes: www.covid19treatmentguidelines.nih.gov/.../management-of-covid-19/

Thank you : -)

Thank you...

Notes for Friday 24, 2020 8:00p.m. Wow! Over 129 + million shares changing hands today. Never could imagine the forces of High-frequency Trader(s), and the loss of control to the upside biases of what they can’t control. The jury has come in and sent all the Threatened or Actual Class Action Suits against Inovio Pharmaceuticals, Inc., as Tweeted and broadcasted, finds on behalf of INO. PT Reminder that we still believe the $37 - $48 as Moderma, Inc., MRNA share price at PT. around $40s - $60 + near-term range. Always trade safely, with keeping your EMOTIONS AT THE TRADING DOOR, and the majority of your trades should do quite well; as its the End-Game that ultimately counts. Be safe and keep praying, as a society, especially for those helping those battling for their lives, and for those who have suffered more than we can imagine; during this China Born Novel Coronavirus COVID19 Pandemic. We, Will, Survive; with keeping God always within the equations—Rebuilding Our Cities, Counties, States, our Country, and our World aa we are more closely connected then we could ever imagine.

Thank you for your incredible High-Frequency Trading Volumes today. Great entry points on the lows, which I will take advantage once the 72 hour clears the SEC 72 Hour insider trading rules seemingly broken by the actions by Citron Research Analyst, and all the law-firms who try driving down Shareholders Values as I covered within this article yesterday.

I was emailed by a few who have read the article. Hopefully it’s helping those trying to invest within INO against the backdrop, understand High-Frequency Traders, who are in this case, Short-Selling based on Citron Twitter Tweet. Our advantage is when they drive share price downward by hitting all the Buy Order Bids and then quickly must buy BACK ON THE ASK SIDE TO COVER THEIR SHORT BORROWING OF SHARES. Our trick of the trade, comes with recognizing the Block Trade indications. For myself, I keep the TotalView of all the Market Makers and the depth in liquidity on ip side and down side ranges. When this is accomplished, I automate my trade triggers to run the Buy and Sell triggers for open orders taking advantage when HFTs are quite identifiable in the increasingly higher volumes seen in your favorite charting systems. I use Point & Figure Charting as its really fined tuned in playing safely with the likes of High-Frequency folks working their Day-Trading need to cover their positions in buying back the INO shares used against those holding Long positions with INOVIO projected 1st Price Target, and then 2nd PT with dollar cost adjusted Averaging within your Long Position Entry. Remember, this one of my greatest rules of NO EMOTIONS just money math with Selling at least 50% to 75% of position when you can see the upward movement in gains equals the original dollar cost averaging of all Purchase Orders ententes, at this point you now are just in the market with the Houses or better said, Market Makers Bank Account or Cash They have within working their daily playbook on INO Share Price Trading Metric of working the markets. So, again, keeping your eyes on the prize is your secret of smartly investing in a quite volatile marketplace with the forces of economic damages wreaked by China’s Novel Coronavirus COVID19 L. Hopefully this makes sense, due in part, as they help Push share price with downward pressure, but they have a harder problem and cannot control the underlying upward pressure of many Institutional Investors, as well as Retail Investors, seeing the Great Reward v Risk in the upside for Inovio INO knowing all these High-Frequency Traders must cover their Short Trade of repaying where they borrowed these shares from Large Market Makers as what makes INO quite explosive for upward or upside momentum with, again, INO is quite ripe if PT of $26 -$36 a share in near term and much higher in achieving the second PT at $68 - $78 dollars a share. Great Swing-Trading Stock issue as Inovio offers as well as purchasing Options that are well seeing greater Open Interest on Call contracts, over the Open Interest on Put Options. Always watch your entry and protect and persevere your capital when investing in any stock securities.

NY Post Article brings greater light upon Inovio’s Vaccine efforts nypost.com/.../coronavirus-vaccine-enters-human-testing-trial/.

We still see INO well undervalued with current discount of 43% to current trading levels for Monday April 13, 2020. Fair value currently is at $12.53